Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary involvement in ulcerative colitis].

O Taguchi1

  • 1Third Department of Internal Medicine, Mie University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oligonucleotide-targeting periostin ameliorates pulmonary fibrosis.

Gene therapy·2017
Same author

Protein S is protective in pulmonary fibrosis.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Circulating fibrocytes correlate with the asthma control test score.

Allergologia et immunopathologia·2016
Same author

Dose-dependent differential effects of thrombin in allergic bronchial asthma.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Collagen markers during anticancer therapy for lung cancer.

Oncology reports·2011
Same author

Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor.

Journal of thrombosis and haemostasis : JTH·2010
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Pulmonary complications, like airway or interstitial lung diseases, are rare but documented in inflammatory bowel disease. Evaluation is crucial, even without symptoms, as these conditions may respond to steroid therapy.

Area of Science:

  • Gastroenterology and Pulmonology
  • Investigates the intersection of gastrointestinal and respiratory systems.

Context:

  • Inflammatory bowel disease (IBD) is increasingly recognized to have extrapulmonary manifestations.
  • Recent literature highlights associations between IBD and specific lung diseases, including bronchiectasis and bronchiolitis obliterans organizing pneumonia (BOOP).

Purpose:

  • To review the occurrence and characteristics of pulmonary involvement in patients with inflammatory bowel disease.
  • To emphasize the importance of evaluating pulmonary function in IBD patients, irrespective of respiratory symptoms.

Summary:

  • Pulmonary complications, though rare, are reported in inflammatory bowel disease patients.
  • Observed lung conditions include airway diseases (bronchiectasis) and interstitial lung diseases (BOOP).

Related Experiment Videos

  • These pulmonary manifestations have shown responsiveness to corticosteroid treatment.

    • Impact:

    • Highlights the need for proactive screening of lung function in all inflammatory bowel disease patients.
    • Suggests that early detection and treatment of pulmonary involvement can improve patient outcomes.
    • Underscores the systemic nature of inflammatory bowel disease and its potential impact on multiple organ systems.